Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126233151 | 12623315 | 1 | I | 20160720 | 20160804 | 20160804 | EXP | 00515215 | CA-HQ SPECIALTY-CA-2016INT000665 | INTERCHEM | 60.00 | YR | F | Y | 0.00000 | 20160804 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126233151 | 12623315 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 2.8571 MG (20 MG, 1 IN 1 W) | U | 201749 | |||||||||
| 126233151 | 12623315 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 0 | |||||||||
| 126233151 | 12623315 | 3 | SS | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 126233151 | 12623315 | 4 | SS | MOBICOX | MELOXICAM | 1 | Unknown | UNK | U | 0 | |||||||||
| 126233151 | 12623315 | 5 | SS | CYTOTEC | MISOPROSTOL | 1 | Unknown | UNK | U | 0 | |||||||||
| 126233151 | 12623315 | 6 | SS | DICLOFENAC | DICLOFENAC | 1 | Unknown | UNK | U | 0 | |||||||||
| 126233151 | 12623315 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 126233151 | 12623315 | 8 | SS | ORENCIA | ABATACEPT | 1 | Subcutaneous | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126233151 | 12623315 | 1 | Rheumatoid arthritis |
| 126233151 | 12623315 | 2 | Rheumatoid arthritis |
| 126233151 | 12623315 | 3 | Product used for unknown indication |
| 126233151 | 12623315 | 4 | Product used for unknown indication |
| 126233151 | 12623315 | 5 | Product used for unknown indication |
| 126233151 | 12623315 | 6 | Product used for unknown indication |
| 126233151 | 12623315 | 7 | Rheumatoid arthritis |
| 126233151 | 12623315 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126233151 | 12623315 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126233151 | 12623315 | Drug hypersensitivity | |
| 126233151 | 12623315 | Rheumatoid arthritis | |
| 126233151 | 12623315 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126233151 | 12623315 | 2 | 2007 | 2013 | 0 | |
| 126233151 | 12623315 | 8 | 201305 | 0 |